Investigation of a high-risk group that should be considered for cognitive function testing in diabetes treatment

Which parameter is specific between normal cognitive function and declined cognitive function in diabetes patients?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN11818569

Enrollment

200

Registered

2019-09-07

Start date

2016-07-17

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

The researchers investigated the following parameters: sex, age, disease duration, body mass index (BMI), smoking, alcohol consumption, family history of diabetes mellitus, coronary artery disease, s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients diagnosed with diabetes mellitus, who were admitted to the Department of Diabetes and Metabolic Diseases at The University of Tokyo Hospital between 17/07/2016 and 31/03/2017

Exclusion criteria

Exclusion criteria: 1. Pregnant 2. Lactating 3. Acute organ failure (e.g., pneumonia, acute myocardial infarction, acute cerebral infarction, diabetic ketoacidosis, and hyperosmolar hyperglycemic state) 4. Congenital cognitive disorders

Design outcomes

Primary

Measure	Time frame
Cognitive dysfunction is measured using the Mini Mental State Examination (MMSE) score after getting consent.	—

Secondary

Measure	Time frame
Oxidative stress is measured using human non-mercaptalbumin (HNA%) from a morning blood test taken on the first day after getting consent.	—

Countries

Japan

Contacts

Public ContactYuka Kobayashi

kobayashiyu-int@h.u-tokyo.ac.jp+81 (0)3 5800 8815

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026